Evidence map›Paper›PMID 28533831›Full record

ArticleThe Pan African medical journal2017

Molecular characterisation of methicillin-resistant Staphylococcus aureus (MRSA) isolated at a large referral hospital in Zambia.

Mulemba Tillika Samutela, Annie Kalonda, James Mwansa, Chileshe Lukwesa-Musyani, John Mwaba, Enoch Mulowa Mumbula, Darlington Mwenya, Edgar Simulundu, Geoffrey Kwenda

Abstract read
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mulemba Tillika SamutelaDepartment of Biomedical Sciences, School of Medicine, University of Zambia,P.O. Box 50110, Lusaka, Zambia.
Annie KalondaDepartment of Biomedical Sciences, School of Medicine, University of Zambia,P.O. Box 50110, Lusaka, Zambia.
James MwansaDepartment of Pathology and Microbiology, University Teaching Hospital, P/Bag RW X1 Lusaka, Zambia.
Chileshe Lukwesa-MusyaniDepartment of Pathology and Microbiology, University Teaching Hospital, P/Bag RW X1 Lusaka, Zambia.
John MwabaDepartment of Pathology and Microbiology, University Teaching Hospital, P/Bag RW X1 Lusaka, Zambia.
Enoch Mulowa MumbulaDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Darlington MwenyaDepartment of Pathology and Microbiology, School of Medicine, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Edgar SimulunduDepartment of Disease Control, School of Veterinary Medicine, University of Zambia, P.O. Box 32379, Lusaka, Zambia.
Geoffrey KwendaDepartment of Biomedical Sciences, School of Medicine, University of Zambia,P.O. Box 50110, Lusaka, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMethicillin-resistant

methodsIn this study, thirty two clinical isolates of

resultsThree SCC

conclusionThese molecular typing data indicated that the MRSA strains collected in Lusaka were diverse. Although the source of these MRSA was not established, these results stress the need for assessing infection prevention and control procedures at this health-care facility in order to curtail possible nosocomial infections. Furthermore, country-wide surveillance of MRSA in both the community and health-care facilities is recommended for infection prevention and control. To our knowledge, this represents the first study to characterise MRSA using molecular tools in Zambia.

Indexed as

Genes, BacterialBacterial ToxinsCross-Sectional StudiesExotoxinsHumansLeukocidinsMethicillin-Resistant Staphylococcus aureusMolecular TypingStaphylococcal InfectionsZambiaBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidinMRSApvlSCCmec typingspatypingZambia

Identifiers

PMID28533831
PMCPMC5429407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.